These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 7832975

  • 1. Modified chemotactic peptides: synthesis and biological activity of HCO-Met-delta ZLeu-delta ZPhe-OMe.
    Pagani Zecchini G, Torrini I, Paglialunga Paradisi M, Lucente G, Spisani S.
    Farmaco; 1994 Nov; 40(11):739-42. PubMed ID: 7832975
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, conformation, and activity of HCO-Met-delta Z Leu-Phe-OMe, an active analogue of chemotactic N-formyltripeptides.
    Pagani Zecchini G, Paglialunga Paradisi M, Torrini I, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Paci M, Sette M, Di Nola A.
    Biopolymers; 1993 Mar; 33(3):437-51. PubMed ID: 8461452
    [Abstract] [Full Text] [Related]

  • 3. Modified chemotactic peptides: synthesis, conformation, and biological activity of For-Thp-Leu-delta ZPhe-OMe.
    Torrini I, Zecchini GP, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S, Cerichelli G.
    Biopolymers; 1994 Oct; 34(10):1291-302. PubMed ID: 7948717
    [Abstract] [Full Text] [Related]

  • 4. Modified chemotactic peptides: synthesis, crystal conformation, and activity of For-Hse(Me)-Leu-Phe-OMe.
    Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.
    Biopolymers; 1994 Jan; 34(1):1-9. PubMed ID: 8110962
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and properties of chemotactic peptide analogs. II. HCO-Met-Leu-Phe-OMe analogs containing cyclic alpha,alpha-disubstituted amino acids as Met and Phe mimicking residues.
    Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Spisani S, Giuliani AL.
    Int J Pept Protein Res; 1991 Dec; 38(6):495-504. PubMed ID: 1668096
    [Abstract] [Full Text] [Related]

  • 6. The role of (Z)-2,3-didehydrophenylalanine and phenylalanine C-terminal residues in determining the chemotactic activity of formylpeptides.
    Torrini I, Zecchini GP, Paradisi MP, Spisani S.
    Arch Pharm (Weinheim); 1996 Mar; 329(3):143-8. PubMed ID: 9005813
    [Abstract] [Full Text] [Related]

  • 7. Modified chemotactic peptides: synthesis, conformation, and activity of HCO-Thp-Ac6c-Phe-OMe.
    Torrini I, Pagani Zecchini G, Paglialunga Paradisi M, Lucente G, Mastropietro G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.
    Biopolymers; 1996 Sep; 39(3):327-37. PubMed ID: 8756513
    [Abstract] [Full Text] [Related]

  • 8. Chemotactic tripeptides incorporating at position 2 alpha-aminoacid residues with unsaturated side chains.
    Lucente G, Paradisi MP, Giordano C, Sansone A, Torino D, Spisani S.
    Amino Acids; 2008 Aug; 35(2):329-38. PubMed ID: 18163179
    [Abstract] [Full Text] [Related]

  • 9. Hybrid alpha/beta3-peptides with proteinogenic side chains. Monosubstituted analogues of the chemotactic tripeptide For-Met-Leu-Phe-OMe.
    Giordano C, Lucente G, Mollica A, Nalli M, Pagani Zecchini G, Paglialunga Paradisi M, Gavuzzo E, Mazza F, Spisani S.
    J Pept Sci; 2004 Aug; 10(8):510-23. PubMed ID: 15347138
    [Abstract] [Full Text] [Related]

  • 10. For-Met-Lys-Phe-For-Met-Lys-Phe-: a new cyclic analogue of the chemotactic formylpeptides.
    Torrini I, Zecchini GP, Paradisi MP, Lucente G, Gavuzzo E, Mazza F, Pochetti G, Traniello S, Spisani S.
    Biopolymers; 1995 Apr; 35(4):347-58. PubMed ID: 7711275
    [Abstract] [Full Text] [Related]

  • 11. New chemotactic dimeric peptides show high affinity and potency at the human formylpeptide receptor.
    Spisani S, Fraulini A, Varani K, Falzarano S, Cavicchioni G.
    Eur J Pharmacol; 2007 Jul 12; 567(1-2):171-6. PubMed ID: 17481605
    [Abstract] [Full Text] [Related]

  • 12. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A, Singh M, Bhandary K, Becker EL, Chauhan VS.
    Pept Res; 1993 Jul 12; 6(6):298-307. PubMed ID: 8292847
    [Abstract] [Full Text] [Related]

  • 13. Novel chemotactic For-Met-Leu-Phe-OMe (fMLF-OMe) analogues based on met residue replacement by 4-amino-proline scaffold: synthesis and bioactivity.
    Torino D, Mollica A, Pinnen F, Feliciani F, Spisani S, Lucente G.
    Bioorg Med Chem; 2009 Jan 01; 17(1):251-9. PubMed ID: 19081258
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis, conformation and biological activity of centrally modified pseudopeptidic analogues of For-Met-Leu-Phe-OMe.
    Giordano C, Lucente G, Masi A, Paglialunga Paradisi M, Sansone A, Spisani S.
    Amino Acids; 2007 Sep 01; 33(3):477-87. PubMed ID: 17021652
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The importance of the peptide bond at position 2 in HCO-Met-Leu-Phe-OMe analogues as shown by studies on human neutrophils.
    Cavicchioni G, Breveglieri A, Boggian M, Vertuani G, Reali E, Spisani S.
    J Pept Sci; 1996 Sep 01; 2(3):135-40. PubMed ID: 9231322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis, biological activity and conformational studies of geometrically restricted tripeptide analogues of the chemoattractant HCO-Met-Leu-Phe-OMe.
    Boggian M, Vertuani G, Cavicchioni G, Pecoraro R, Scatturin A, Spisani S.
    Farmaco; 1997 Sep 01; 52(6-7):439-44. PubMed ID: 9372595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.